Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm is ramping up production for expected 2012 launch of the Solo pump.

You may also be interested in...



With One Foot Firmly Planted In Oncology, Roche Moves The Other Into CV/Metabolic

The Swiss drug maker, long a leader in oncology, is vying to become a frontrunner in treating cardiovascular disease and metabolic disorders.

Medingo deal?

Developer of the Solo miniature insulin dispensing patch pump, which is 92% owned by diversified conglomerate Elron, could be sold for up to $213 million, including milestone payments, based on a "non-binding indication of interest" from an un-named third party, Elron says Oct. 26. But a Medingo deal would be subject to signing of a definitive agreement, and currently "there is no assurance of the occurrence, timing or terms of any such transaction," the firm says

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

UsernamePublicRestriction

Register

PS070482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel